Some recent studies demonstrated that GLP-1 RAs may be useful for the treatment of chronic inflammatory diseases including nonalcoholic steatohepatitis, atherosclerosis, neurodegenerative disorders, diabetic nephropathy, asthma, and psoriasis [15,16,17]. This evidence concerns the gene GLP1R and metabolic dysfunction-associated steatohepatitis.